>Ooops - I almost forgot the most important thing. If you are taking
>5AR2 inhibitors (which you have to in order to lower DHT), you must
>avoid all soy, flaxseed, isoflavenes, etc. - anything that binds
>specifically to ER-beta.
>
>Ed Friedman
>>Ooops - I almost forgot the most important thing. If you are taking
>>5AR2 inhibitors (which you have to in order to lower DHT), you must
[quoted text clipped - 6 lines]
>
> Ed
Ed,
If you go to the web site:
http://www.prostatepointers.org/leibowitz/vitaminlist.10103.html
and search for genistein, you will see that this has behavior has been
observed in actual patients.
The theory comes directly from my paper (the references are in the
paper). My next paper will try to clarify this whole issue. But to
summarize the first paper:
1.) Mice with a genetic mutation lacking ER-beta have lots of bcl-2 in
their prostates. I'm unable to come up with any explanation for this
fact other than ER-beta decreases the production of bcl-2 (bcl-2 is
what protects prostate cancer from apoptosis).
2.) DHT binding to the intracellular androgen receptor decreases the
production of bcl-2. There was a direct experiment that showed that.
Therefore, if you are using any drug that lowers DHT production, you are
more dependent on ER-beta to keep bcl-2 production low. Since the
protein genestein which is found in soy binds preferentially to ER-beta
over ER-alpha by a ratio of over 40 to 1, the more soy you take, the
lower the rate of apoptosis and the faster the overall growth rate of
the prostate cancer population.
Ed Friedman
Ed - 09 Aug 2005 17:46 GMT
>>>Ooops - I almost forgot the most important thing. If you are taking
>>>5AR2 inhibitors (which you have to in order to lower DHT), you must
[quoted text clipped - 34 lines]
>
>Ed Friedman
ER-beta? bcl-2? Apoptosis?
Anyway, I think you are saying that this recommendation is relative to
prostate cancer, not BPH.
Ed